BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15184884)

  • 21. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.
    Chen W; Salto-Tellez M; Palanisamy N; Ganesan K; Hou Q; Tan LK; Sii LH; Ito K; Tan B; Wu J; Tay A; Tan KC; Ang E; Tan BK; Tan PH; Ito Y; Tan P
    Genes Chromosomes Cancer; 2007 Mar; 46(3):288-301. PubMed ID: 17171680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of 8p loss in transformed human prostate epithelial cells.
    Macoska JA; Paris P; Collins C; Andaya A; Beheshti B; Chaib H; Kant R; Begley L; MacDonald JW; Squire JA
    Cancer Genet Cytogenet; 2004 Oct; 154(1):36-43. PubMed ID: 15381370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
    Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
    Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TP53 mutations are associated with a particular pattern of genomic imbalances in breast carcinomas.
    Kleivi K; Diep CB; Pandis N; Heim S; Teixeira MR; Lothe RA
    J Pathol; 2005 Sep; 207(1):14-9. PubMed ID: 16007576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer.
    Cleton-Jansen AM; Buerger H; Haar Nt; Philippo K; van de Vijver MJ; Boecker W; Smit VT; Cornelisse CJ
    Genes Chromosomes Cancer; 2004 Oct; 41(2):109-16. PubMed ID: 15287023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
    Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
    Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
    Andre F; Job B; Dessen P; Tordai A; Michiels S; Liedtke C; Richon C; Yan K; Wang B; Vassal G; Delaloge S; Hortobagyi GN; Symmans WF; Lazar V; Pusztai L
    Clin Cancer Res; 2009 Jan; 15(2):441-51. PubMed ID: 19147748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three discrete areas within the chromosomal 8p21.3-23 region are associated with the development of breast carcinoma of Indian patients.
    Bhattacharya N; Chunder N; Basu D; Roy A; Mandal S; Majumder J; Roychowdhury S; Panda CK
    Exp Mol Pathol; 2004 Jun; 76(3):264-71. PubMed ID: 15126110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ST18 is a breast cancer tumor suppressor gene at human chromosome 8q11.2.
    Jandrig B; Seitz S; Hinzmann B; Arnold W; Micheel B; Koelble K; Siebert R; Schwartz A; Ruecker K; Schlag PM; Scherneck S; Rosenthal A
    Oncogene; 2004 Dec; 23(57):9295-302. PubMed ID: 15489893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased copy number at 3p14 in breast cancer.
    Ljuslinder I; Malmer B; Golovleva I; Thomasson M; Grankvist K; Höckenström T; Emdin S; Jonsson Y; Hedman H; Henriksson R
    Breast Cancer Res; 2005; 7(5):R719-27. PubMed ID: 16168117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of heterozygosity in familial breast carcinomas.
    Lindblom A; Skoog L; Rotstein S; Werelius B; Larsson C; Nordenskjöld M
    Cancer Res; 1993 Sep; 53(18):4356-61. PubMed ID: 8364930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity.
    Kremmidiotis G; Baker E; Crawford J; Eyre HJ; Nahmias J; Callen DF
    Genomics; 1998 May; 49(3):467-71. PubMed ID: 9615235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma.
    De Rienzo A; Balsara BR; Apostolou S; Jhanwar SC; Testa JR
    Oncogene; 2001 Sep; 20(43):6245-9. PubMed ID: 11593434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of chromosome band 8q22 copy number gain with high grade invasive breast carcinomas by assessment of core needle biopsies.
    Walker LC; Harris GC; Wells JE; Robinson BA; Morris CM
    Genes Chromosomes Cancer; 2008 May; 47(5):405-17. PubMed ID: 18273837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast.
    Green AR; Krivinskas S; Young P; Rakha EA; Paish EC; Powe DG; Ellis IO
    Breast Cancer Res Treat; 2009 Jan; 113(1):59-66. PubMed ID: 18213475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene.
    Martin ES; Cesari R; Pentimalli F; Yoder K; Fishel R; Himelstein AL; Martin SE; Godwin AK; Negrini M; Croce CM
    Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11517-22. PubMed ID: 14504409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression.
    Seitz S; Korsching E; Weimer J; Jacobsen A; Arnold N; Meindl A; Arnold W; Gustavus D; Klebig C; Petersen I; Scherneck S
    Genes Chromosomes Cancer; 2006 Jun; 45(6):612-27. PubMed ID: 16552773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of chromosomal aneuploidies and gene copy number changes in fine needle aspirates is a specific, sensitive, and objective genetic test for the diagnosis of breast cancer.
    Heselmeyer-Haddad K; Chaudhri N; Stoltzfus P; Cheng JC; Wilber K; Morrison L; Auer G; Ried T
    Cancer Res; 2002 Apr; 62(8):2365-9. PubMed ID: 11956098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.
    Knowles MA; Aveyard JS; Taylor CF; Harnden P; Bass S
    Cancer Lett; 2005 Jul; 225(1):121-30. PubMed ID: 15922864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.